However, to date, no UK-specific national guideline exists that directly addresses switching from tirzepatide to semaglutide
Your healthcare provider may need to adjust other diabetes medications, such as increasing metformin doses, adding SGLT2 inhibitors or DPP-4 inhibitors, or adjusting insulin regimens
AusPAR: Semaglutida
However, based on their pharmacological profiles, the risk of direct interaction appears low because they operate on entirely separate receptor systems
This plan might include a combination of medications, lifestyle changes, and dietary adjustments to ensure the best results
This approach allows the digestive system to adapt, particularly important given the already altered gut motility from GLP-1 medications